Page 311 - ATP-P 11th Ed
P. 311

•   Pain at injection site
        •   Nausea and vomiting
        Adverse reactions:
        •   Bradycardia
        •   CV collapse
        •   Amnesia
        •   Abdominal discomfort
        TMEP use:
        •   Back Pain Protocol
        •   Behavioral Changes Protocol
        •  Heat Illness Protocol
        •  K9 RDX (C-4) Ingestion Protocol
        •   Seizure Protocol
        TTP use: Head injury induced seizures

              ®
        Diflucan  – See Fluconazole
                                ®
        Diphenhydramine HCl (Benadryl )                                       SECTION 3
              GROUNDING medication for personnel on flight status
        Description: Antihistamine. Prevents (but does not reverse) histamine-mediated responses.
        H1 blocker
        Indications:
        •   Mild to moderate allergic symptoms and/or allergic reactions
        •   Dystonic reaction
        Adult dose: 25–50mg IM/IV/PO q6hr; max dose 400mg/day
        Pediatric dose: Children <12 years: 5mg/kg/day in divided doses qid PO/IM/IV
             K9 Dose: 1–2 mg/kg SC, IM, or PO (capsules)
        Contraindications:
        •   Asthma
        •   Pregnant or lactating females
        Pregnancy Category C
        Side-effects:
        •   Sedation
        •   Blurred vision
        •   Nausea
        •   Vomiting
        •   Diarrhea
        •   Headache
        Adverse reactions:
        •   Insomnia

                                              ATP-P Handbook 11th Edition 301
   306   307   308   309   310   311   312   313   314   315   316